SCHEMBL1835296

SCHEMBL1835296

CCCCC(CC)COCCOCC(CC)CCCC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.74
ALDH1A1 P00352 7/20 0.56
L3MBTL1 Q9Y468 1/20 0.55
MMP9 P14780 1/20 0.54
MMP8 P22894 1/20 0.54
MMP14 P50281 1/20 0.54
TSHR P16473 4/20 0.50
TDP1 Q9NUW8 2/20 0.50
ATM Q13315 1/20 0.50
CA2 P00918 3/20 0.43
RECQL P46063 1/20 0.41
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
PLA2G2C Q5R387 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1839353 0.98 CYP3A4 (0.71) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL11905467 0.98 CYP3A4 (0.71) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL3765751 0.98 CYP3A4 (0.71) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
Ethylene SCHEMBL15254964 0.94 CYP3A4 (0.67) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL20725831 0.94 CYP3A4 (0.67) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL1710091 0.94 CYP3A4 (0.67) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL1069293 0.94 CYP3A4 (0.67) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL29886916 0.94 CYP3A4 (0.72) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL3432858 0.93 CYP3A4 (0.71) CYP3A4ALDH1A1L3MBTL1MMP9MMP8
SCHEMBL2241603 0.93 CYP3A4 (0.78) CYP3A4ALDH1A1L3MBTL1MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110218285-A1 LOW VOC ADDITIVES FOR EXTENDING THE WET EDGE AND OPEN TIME OF AQUEOUS COATINGS EASTMAN CHEMICAL COMPANY (US) 2011-09-08 US claimed
EP-1628320-B1 Barrier rib formation composition for manufacturing plasma display panel LG ELECTRONICS INC (KR) 2010-03-03 EP claimed
US-7442738-B2 Barrier rib formation composition for manufacturing plasma display panel LG ELECTRONICS INC. (KR) 2008-10-28 US claimed
EP-1628320-A1 Barrier rib formation composition for manufacturing plasma display panel LG Electronics Inc. (KR) 2006-02-22 EP claimed
US-20060020050-A1 Barrier rib formation composition for manufacturing plasma display panel LG ELECTRONICS INC. 2006-01-26 US claimed
EP-4298181-B1 METHOD, BATTERY SYSTEM AND THERMAL MANAGEMENT CIRCUIT USING A DIELECTRIC THERMAL MANAGEMENT FLUID CASTROL LTD (GB) 2025-05-28 EP disclosed
US-20240150636-A1 Dielectric Thermal Management Fluids and Methods for Using Them CASTROL LIMITED (GB) 2024-05-09 US disclosed
US-20240052068-A1 WATERBASED BINDER FOR TWO-COMPONENT COATING COMPOSITION BASF SE (DE) 2024-02-15 US disclosed
EP-4298181-A1 DIELECTRIC THERMAL MANAGEMENT FLUIDS AND METHODS FOR USING THEM Castrol Limited (GB) 2024-01-03 EP disclosed
CN-117203304-A Dielectric thermal management fluid and method of use thereof 卡斯特罗尔有限公司 2023-12-08 CN disclosed
US-20230357591-A1 PROCESS OF COATING WOOD BASF SE (DE) 2023-11-09 US disclosed
EP-3848209-B1 TIRE AND METHOD OF EVALUATING TIRE GRIP PERFORMANCE SUMITOMO RUBBER IND (JP) 2023-11-01 EP disclosed
US-20090326121-A1 LOW VOC ADDITIVES FOR EXTENDING THE WET EDGE AND OPEN TIME OF AQUEOUS COATINGS EASTMAN CHEMICAL COMPANY (US) 2009-12-31 US disclosed
US-7442738-B2 Barrier rib formation composition for manufacturing plasma display panel LG ELECTRONICS INC. (KR) 2008-10-28 US disclosed
US-20070281873-A1 Lubricant Composition for Fluid Dynamic Bearing IDEMITSU KOSAN CO., LTD (JP) 2007-12-06 US disclosed
US-20070225451-A1 uretidone-containing compound from the reaction of a diisocyanate and alcohol; biuret derivative as end group for polyoxyethylene glycol;used in thixotroping coating systems for creep resistance and nonsettling properties; improved effect profile and improved reproducibility of thixotroping BYK-CHEMIE GMBH (DE) 2007-09-27 US disclosed
EP-1628320-A1 Barrier rib formation composition for manufacturing plasma display panel LG Electronics Inc. (KR) 2006-02-22 EP disclosed
US-20060020050-A1 Barrier rib formation composition for manufacturing plasma display panel LG ELECTRONICS INC. 2006-01-26 US disclosed
EP-0334956-A1 HEMOLYSIS INHIBITOR AND MEDICAL RESIN COMPOSITION, MEDICAL IMPLEMENT, AND BLOOD-PRESERVING FLUID CONTAINING THE SAME Kao Corporation (JP) 1989-10-04 EP disclosed
US-4301083-A BY REACTION WITH AN ORGANIC CHLORIDE OR BROMIDE IN THE PRESENCE OF SODIUM OR POTASSIUM HYDROXIDE KURARAY CO., LTD. (JP) 1981-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281873-A1 Lubricant Composition for Fluid Dynamic Bearing SELE, PHOSPHO1, SRC CYP3A4 3847/4885ALDH1A1 4571/4885L3MBTL1 3202/4885
US-20240150636-A1 Dielectric Thermal Management Fluids and Methods for Using Them KIF11, KIF2C, KIF23 CYP3A4 3256/4885ALDH1A1 1758/4885L3MBTL1 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.